APO Research

APO RESEARCH · REPORT

Animal Pharmaceutical

Selected research

Market Analysis & Forecast

Global Animal Pharmaceutical Market Analysis and Forecast 2026-2032

Market perspective

The global Animal Pharmaceutical market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Animal Pharmaceutical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Animal Pharmaceutical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Animal Pharmaceutical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Animal Pharmaceutical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Animal Pharmaceutical include Merck, Zoetis, Virbac, Vétoquinol, Ringpu Biology, PARNELL, MSD Animal Health Australia, Merial and Jurox, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Animal Pharmaceutical, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Animal Pharmaceutical, also provides the sales of main regions and countries. Of the upcoming market potential for Animal Pharmaceutical, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Animal Pharmaceutical sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Animal Pharmaceutical market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Animal Pharmaceutical sales, projected growth trends, production technology, application and end-user industry.

Animal Pharmaceutical Segment by Company

Merck

Zoetis

Virbac

Vétoquinol

Ringpu Biology

PARNELL

MSD Animal Health Australia

Merial

Jurox

Elanco

Ceva Sante Animale

CAHIC

Boehringer Ingelheim Vetmedica

Bayer Animal Health

Animal Pharmaceutical Segment by Type

Vaccine

Veterinary Drugs

Other

Animal Pharmaceutical Segment by Application

Companion Animal

Poultry

Other

Animal Pharmaceutical Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Pharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Animal Pharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Pharmaceutical.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Animal Pharmaceutical in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Animal Pharmaceutical manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Animal Pharmaceutical sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Animal Pharmaceutical Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Vaccine Major Manufacturers Table 3. Veterinary Drugs Major Manufacturers Table 4. Other Major Manufacturers Table 5. Global Animal Pharmaceutical Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Companion Animal Major Manufacturers Table 7. Poultry Major Manufacturers Table 8. Other Major Manufacturers Table 9. Animal Pharmaceutical Industry Trends Table 10. Animal Pharmaceutical Industry Drivers Table 11. Animal Pharmaceutical Industry Opportunities and Challenges Table 12. Animal Pharmaceutical Industry Restraints Table 13. Global Animal Pharmaceutical Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Animal Pharmaceutical Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Animal Pharmaceutical Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Animal Pharmaceutical Revenue Market Share by Region (2021-2026) Table 17. Global Animal Pharmaceutical Revenue Market Share by Region (2027-2032) Table 18. Global Animal Pharmaceutical Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 19. Global Animal Pharmaceutical Sales by Region (2021-2026) & (Tons) Table 20. Global Animal Pharmaceutical Sales by Region (2027-2032) & (Tons) Table 21. Global Animal Pharmaceutical Sales Market Share by Region (2021-2026) Table 22. Global Animal Pharmaceutical Sales Market Share by Region (2027-2032) Table 23. Global Animal Pharmaceutical Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Animal Pharmaceutical Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Animal Pharmaceutical Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Animal Pharmaceutical Sales Market Share by Manufacturers (2021-2026) Table 27. Global Animal Pharmaceutical Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 28. Global Animal Pharmaceutical Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Animal Pharmaceutical Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Animal Pharmaceutical Manufacturers, Product Type & Application Table 31. Global Animal Pharmaceutical Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Animal Pharmaceutical by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Animal Pharmaceutical Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Animal Pharmaceutical Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Animal Pharmaceutical Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Animal Pharmaceutical Revenue Market Share by Type (2021-2026) Table 38. Global Animal Pharmaceutical Revenue Market Share by Type (2027-2032) Table 39. Global Animal Pharmaceutical Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 40. Global Animal Pharmaceutical Sales by Type (2021-2026) & (Tons) Table 41. Global Animal Pharmaceutical Sales by Type (2027-2032) & (Tons) Table 42. Global Animal Pharmaceutical Sales Market Share by Type (2021-2026) Table 43. Global Animal Pharmaceutical Sales Market Share by Type (2027-2032) Table 44. Global Animal Pharmaceutical Price by Type (2021-2026) & (US$/Ton) Table 45. Global Animal Pharmaceutical Price by Type (2027-2032) & (US$/Ton) Table 46. Global Animal Pharmaceutical Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Animal Pharmaceutical Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Animal Pharmaceutical Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Animal Pharmaceutical Revenue Market Share by Application (2021-2026) Table 50. Global Animal Pharmaceutical Revenue Market Share by Application (2027-2032) Table 51. Global Animal Pharmaceutical Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 52. Global Animal Pharmaceutical Sales by Application (2021-2026) & (Tons) Table 53. Global Animal Pharmaceutical Sales by Application (2027-2032) & (Tons) Table 54. Global Animal Pharmaceutical Sales Market Share by Application (2021-2026) Table 55. Global Animal Pharmaceutical Sales Market Share by Application (2027-2032) Table 56. Global Animal Pharmaceutical Price by Application (2021-2026) & (US$/Ton) Table 57. Global Animal Pharmaceutical Price by Application (2027-2032) & (US$/Ton) Table 58. Merck Company Information Table 59. Merck Business Overview Table 60. Merck Animal Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 61. Merck Animal Pharmaceutical Product Portfolio Table 62. Merck Recent Development Table 63. Zoetis Company Information Table 64. Zoetis Business Overview Table 65. Zoetis Animal Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. Zoetis Animal Pharmaceutical Product Portfolio Table 67. Zoetis Recent Development Table 68. Virbac Company Information Table 69. Virbac Business Overview Table 70. Virbac Animal Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. Virbac Animal Pharmaceutical Product Portfolio Table 72. Virbac Recent Development Table 73. Vétoquinol Company Information Table 74. Vétoquinol Business Overview Table 75. Vétoquinol Animal Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Vétoquinol Animal Pharmaceutical Product Portfolio Table 77. Vétoquinol Recent Development Table 78. Ringpu Biology Company Information Table 79. Ringpu Biology Business Overview Table 80. Ringpu Biology Animal Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Ringpu Biology Animal Pharmaceutical Product Portfolio Table 82. Ringpu Biology Recent Development Table 83. PARNELL Company Information Table 84. PARNELL Business Overview Table 85. PARNELL Animal Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. PARNELL Animal Pharmaceutical Product Portfolio Table 87. PARNELL Recent Development Table 88. MSD Animal Health Australia Company Information Table 89. MSD Animal Health Australia Business Overview Table 90. MSD Animal Health Australia Animal Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. MSD Animal Health Australia Animal Pharmaceutical Product Portfolio Table 92. MSD Animal Health Australia Recent Development Table 93. Merial Company Information Table 94. Merial Business Overview Table 95. Merial Animal Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Merial Animal Pharmaceutical Product Portfolio Table 97. Merial Recent Development Table 98. Jurox Company Information Table 99. Jurox Business Overview Table 100. Jurox Animal Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Jurox Animal Pharmaceutical Product Portfolio Table 102. Jurox Recent Development Table 103. Elanco Company Information Table 104. Elanco Business Overview Table 105. Elanco Animal Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Elanco Animal Pharmaceutical Product Portfolio Table 107. Elanco Recent Development Table 108. Ceva Sante Animale Company Information Table 109. Ceva Sante Animale Business Overview Table 110. Ceva Sante Animale Animal Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. Ceva Sante Animale Animal Pharmaceutical Product Portfolio Table 112. Ceva Sante Animale Recent Development Table 113. CAHIC Company Information Table 114. CAHIC Business Overview Table 115. CAHIC Animal Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 116. CAHIC Animal Pharmaceutical Product Portfolio Table 117. CAHIC Recent Development Table 118. Boehringer Ingelheim Vetmedica Company Information Table 119. Boehringer Ingelheim Vetmedica Business Overview Table 120. Boehringer Ingelheim Vetmedica Animal Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 121. Boehringer Ingelheim Vetmedica Animal Pharmaceutical Product Portfolio Table 122. Boehringer Ingelheim Vetmedica Recent Development Table 123. Bayer Animal Health Company Information Table 124. Bayer Animal Health Business Overview Table 125. Bayer Animal Health Animal Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 126. Bayer Animal Health Animal Pharmaceutical Product Portfolio Table 127. Bayer Animal Health Recent Development Table 128. North America Animal Pharmaceutical Revenue by Type (2021-2026) & (US$ Million) Table 129. North America Animal Pharmaceutical Revenue by Type (2027-2032) & (US$ Million) Table 130. North America Animal Pharmaceutical Sales by Type (2021-2026) & (Tons) Table 131. North America Animal Pharmaceutical Sales by Type (2027-2032) & (Tons) Table 132. North America Animal Pharmaceutical Sales Price by Type (2021-2026) & (US$/Ton) Table 133. North America Animal Pharmaceutical Sales Price by Type (2027-2032) & (US$/Ton) Table 134. North America Animal Pharmaceutical Revenue by Application (2021-2026) & (US$ Million) Table 135. North America Animal Pharmaceutical Revenue by Application (2027-2032) & (US$ Million) Table 136. North America Animal Pharmaceutical Sales by Application (2021-2026) & (Tons) Table 137. North America Animal Pharmaceutical Sales by Application (2027-2032) & (Tons) Table 138. North America Animal Pharmaceutical Sales Price by Application (2021-2026) & (US$/Ton) Table 139. North America Animal Pharmaceutical Sales Price by Application (2027-2032) & (US$/Ton) Table 140. North America Animal Pharmaceutical Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. North America Animal Pharmaceutical Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 142. North America Animal Pharmaceutical Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 143. North America Animal Pharmaceutical Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 144. North America Animal Pharmaceutical Sales by Country (2021-2026) & (Tons) Table 145. North America Animal Pharmaceutical Sales by Country (2027-2032) & (Tons) Table 146. North America Animal Pharmaceutical Sales Price by Country (2021-2026) & (US$/Ton) Table 147. North America Animal Pharmaceutical Sales Price by Country (2027-2032) & (US$/Ton) Table 148. United States Animal Pharmaceutical Revenue (2021-2032) & (US$ Million) Table 149. Canada Animal Pharmaceutical Revenue (2021-2032) & (US$ Million) Table 150. Mexico Animal Pharmaceutical Revenue (2021-2032) & (US$ Million) Table 151. Europe Animal Pharmaceutical Revenue by Type (2021-2026) & (US$ Million) Table 152. Europe Animal Pharmaceutical Revenue by Type (2027-2032) & (US$ Million) Table 153. Europe Animal Pharmaceutical Sales by Type (2021-2026) & (Tons) Table 154. Europe Animal Pharmaceutical Sales by Type (2027-2032) & (Tons) Table 155. Europe Animal Pharmaceutical Sales Price by Type (2021-2026) & (US$/Ton) Table 156. Europe Animal Pharmaceutical Sales Price by Type (2027-2032) & (US$/Ton) Table 157. Europe Animal Pharmaceutical Revenue by Application (2021-2026) & (US$ Million) Table 158. Europe Animal Pharmaceutical Revenue by Application (2027-2032) & (US$ Million) Table 159. Europe Animal Pharmaceutical Sales by Application (2021-2026) & (Tons) Table 160. Europe Animal Pharmaceutical Sales by Application (2027-2032) & (Tons) Table 161. Europe Animal Pharmaceutical Sales Price by Application (2021-2026) & (US$/Ton) Table 162. Europe Animal Pharmaceutical Sales Price by Application (2027-2032) & (US$/Ton) Table 163. Europe Animal Pharmaceutical Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. Europe Animal Pharmaceutical Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 165. Europe Animal Pharmaceutical Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 166. Europe Animal Pharmaceutical Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 167. Europe Animal Pharmaceutical Sales by Country (2021-2026) & (Tons) Table 168. Europe Animal Pharmaceutical Sales by Country (2027-2032) & (Tons) Table 169. Europe Animal Pharmaceutical Sales Price by Country (2021-2026) & (US$/Ton) Table 170. Europe Animal Pharmaceutical Sales Price by Country (2027-2032) & (US$/Ton) Table 171. Germany Animal Pharmaceutical Revenue (2021-2032) & (US$ Million) Table 172. France Animal Pharmaceutical Revenue (2021-2032) & (US$ Million) Table 173. U.K. Animal Pharmaceutical Revenue (2021-2032) & (US$ Million) Table 174. Italy Animal Pharmaceutical Revenue (2021-2032) & (US$ Million) Table 175. Russia Animal Pharmaceutical Revenue (2021-2032) & (US$ Million) Table 176. Spain Animal Pharmaceutical Revenue (2021-2032) & (US$ Million) Table 177. Netherlands Animal Pharmaceutical Revenue (2021-2032) & (US$ Million) Table 178. Switzerland Animal Pharmaceutical Revenue (2021-2032) & (US$ Million) Table 179. Sweden Animal Pharmaceutical Revenue (2021-2032) & (US$ Million) Table 180. Poland Animal Pharmaceutical Revenue (2021-2032) & (US$ Million) Table 181. China Animal Pharmaceutical Revenue by Type (2021-2026) & (US$ Million) Table 182. China Animal Pharmaceutical Revenue by Type (2027-2032) & (US$ Million) Table 183. China Animal Pharmaceutical Sales by Type (2021-2026) & (Tons) Table 184. China Animal Pharmaceutical Sales by Type (2027-2032) & (Tons) Table 185. China Animal Pharmaceutical Sales Price by Type (2021-2026) & (US$/Ton) Table 186. China Animal Pharmaceutical Sales Price by Type (2027-2032) & (US$/Ton) Table 187. China Animal Pharmaceutical Revenue by Application (2021-2026) & (US$ Million) Table 188. China Animal Pharmaceutical Revenue by Application (2027-2032) & (US$ Million) Table 189. China Animal Pharmaceutical Sales by Application (2021-2026) & (Tons) Table 190. China Animal Pharmaceutical Sales by Application (2027-2032) & (Tons) Table 191. China Animal Pharmaceutical Sales Price by Application (2021-2026) & (US$/Ton) Table 192. China Animal Pharmaceutical Sales Price by Application (2027-2032) & (US$/Ton) Table 193. Asia Animal Pharmaceutical Revenue by Type (2021-2026) & (US$ Million) Table 194. Asia Animal Pharmaceutical Revenue by Type (2027-2032) & (US$ Million) Table 195. Asia Animal Pharmaceutical Sales by Type (2021-2026) & (Tons) Table 196. Asia Animal Pharmaceutical Sales by Type (2027-2032) & (Tons) Table 197. Asia Animal Pharmaceutical Sales Price by Type (2021-2026) & (US$/Ton) Table 198. Asia Animal Pharmaceutical Sales Price by Type (2027-2032) & (US$/Ton) Table 199. Asia Animal Pharmaceutical Revenue by Application (2021-2026) & (US$ Million) Table 200. Asia Animal Pharmaceutical Revenue by Application (2027-2032) & (US$ Million) Table 201. Asia Animal Pharmaceutical Sales by Application (2021-2026) & (Tons) Table 202. Asia Animal Pharmaceutical Sales by Application (2027-2032) & (Tons) Table 203. Asia Animal Pharmaceutical Sales Price by Application (2021-2026) & (US$/Ton) Table 204. Asia Animal Pharmaceutical Sales Price by Application (2027-2032) & (US$/Ton) Table 205. Asia Animal Pharmaceutical Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 206. Asia Animal Pharmaceutical Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 207. Asia Animal Pharmaceutical Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 208. Asia Animal Pharmaceutical Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 209. Asia Animal Pharmaceutical Sales by Country (2021-2026) & (Tons) Table 210. Asia Animal Pharmaceutical Sales by Country (2027-2032) & (Tons) Table 211. Asia Animal Pharmaceutical Sales Price by Country (2021-2026) & (US$/Ton) Table 212. Asia Animal Pharmaceutical Sales Price by Country (2027-2032) & (US$/Ton) Table 213. Japan Animal Pharmaceutical Revenue (2021-2032) & (US$ Million) Table 214. South Korea Animal Pharmaceutical Revenue (2021-2032) & (US$ Million) Table 215. India Animal Pharmaceutical Revenue (2021-2032) & (US$ Million) Table 216. Australia Animal Pharmaceutical Revenue (2021-2032) & (US$ Million) Table 217. Taiwan Animal Pharmaceutical Revenue (2021-2032) & (US$ Million) Table 218. Southeast Asia Animal Pharmaceutical Revenue (2021-2032) & (US$ Million) Table 219. SAMEA Animal Pharmaceutical Revenue by Type (2021-2026) & (US$ Million) Table 220. SAMEA Animal Pharmaceutical Revenue by Type (2027-2032) & (US$ Million) Table 221. SAMEA Animal Pharmaceutical Sales by Type (2021-2026) & (Tons) Table 222. SAMEA Animal Pharmaceutical Sales by Type (2027-2032) & (Tons) Table 223. SAMEA Animal Pharmaceutical Sales Price by Type (2021-2026) & (US$/Ton) Table 224. SAMEA Animal Pharmaceutical Sales Price by Type (2027-2032) & (US$/Ton) Table 225. SAMEA Animal Pharmaceutical Revenue by Application (2021-2026) & (US$ Million) Table 226. SAMEA Animal Pharmaceutical Revenue by Application (2027-2032) & (US$ Million) Table 227. SAMEA Animal Pharmaceutical Sales by Application (2021-2026) & (Tons) Table 228. SAMEA Animal Pharmaceutical Sales by Application (2027-2032) & (Tons) Table 229. SAMEA Animal Pharmaceutical Sales Price by Application (2021-2026) & (US$/Ton) Table 230. SAMEA Animal Pharmaceutical Sales Price by Application (2027-2032) & (US$/Ton) Table 231. SAMEA Animal Pharmaceutical Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 232. SAMEA Animal Pharmaceutical Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 233. SAMEA Animal Pharmaceutical Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 234. SAMEA Animal Pharmaceutical Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 235. SAMEA Animal Pharmaceutical Sales by Country (2021-2026) & (Tons) Table 236. SAMEA Animal Pharmaceutical Sales by Country (2027-2032) & (Tons) Table 237. SAMEA Animal Pharmaceutical Sales Price by Country (2021-2026) & (US$/Ton) Table 238. SAMEA Animal Pharmaceutical Sales Price by Country (2027-2032) & (US$/Ton) Table 239. Brazil Animal Pharmaceutical Revenue (2021-2032) & (US$ Million) Table 240. Argentina Animal Pharmaceutical Revenue (2021-2032) & (US$ Million) Table 241. Chile Animal Pharmaceutical Revenue (2021-2032) & (US$ Million) Table 242. Colombia Animal Pharmaceutical Revenue (2021-2032) & (US$ Million) Table 243. Peru Animal Pharmaceutical Revenue (2021-2032) & (US$ Million) Table 244. Saudi Arabia Animal Pharmaceutical Revenue (2021-2032) & (US$ Million) Table 245. Israel Animal Pharmaceutical Revenue (2021-2032) & (US$ Million) Table 246. UAE Animal Pharmaceutical Revenue (2021-2032) & (US$ Million) Table 247. Turkey Animal Pharmaceutical Revenue (2021-2032) & (US$ Million) Table 248. Iran Animal Pharmaceutical Revenue (2021-2032) & (US$ Million) Table 249. Egypt Animal Pharmaceutical Revenue (2021-2032) & (US$ Million) Table 250. Key Raw Materials Table 251. Raw Materials Key Suppliers Table 252. Animal Pharmaceutical Distributors List Table 253. Animal Pharmaceutical Customers List Table 254. Research Programs/Design for This Report Table 255. Authors List of This Report Table 256. Secondary Sources Table 257. Primary Sources List of Figures Figure 1. Animal Pharmaceutical Image Figure 2. Global Animal Pharmaceutical Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Animal Pharmaceutical Market Size Share 2021 VS 2025 VS 2032 Figure 4. Vaccine Image Figure 5. Veterinary Drugs Image Figure 6. Other Image Figure 7. Global Animal Pharmaceutical Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Animal Pharmaceutical Market Size Share 2021 VS 2025 VS 2032 Figure 9. Companion Animal Image Figure 10. Poultry Image Figure 11. Other Image Figure 12. Global Animal Pharmaceutical Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Animal Pharmaceutical Revenue (2021-2032) & (US$ Million) Figure 14. Global Animal Pharmaceutical Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Animal Pharmaceutical Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Animal Pharmaceutical Revenue Market Share by Region (2021-2032) Figure 17. Global Animal Pharmaceutical Sales (2021-2032) & (Tons) Figure 18. Global Animal Pharmaceutical Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 19. Global Animal Pharmaceutical Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Animal Pharmaceutical Sales YoY (2021-2032) & (Tons) Figure 21. Europe Animal Pharmaceutical Sales YoY (2021-2032) & (Tons) Figure 22. China Animal Pharmaceutical Sales YoY (2021-2032) & (Tons) Figure 23. Asia (Excluding China) Animal Pharmaceutical Sales YoY (2021-2032) & (Tons) Figure 24. South America, Middle East and Africa Animal Pharmaceutical Sales YoY (2021-2032) & (Tons) Figure 25. Global Animal Pharmaceutical Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Animal Pharmaceutical Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Animal Pharmaceutical Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Animal Pharmaceutical Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Animal Pharmaceutical Revenue Market Share by Type (2021-2032) Figure 31. Global Animal Pharmaceutical Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 32. Global Animal Pharmaceutical Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Animal Pharmaceutical Sales Market Share by Type (2021-2032) Figure 34. Global Animal Pharmaceutical Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Animal Pharmaceutical Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Animal Pharmaceutical Revenue Market Share by Application (2021-2032) Figure 37. Global Animal Pharmaceutical Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 38. Global Animal Pharmaceutical Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Animal Pharmaceutical Sales Market Share by Application (2021-2032) Figure 40. North America Animal Pharmaceutical Revenue Share by Type (2021-2032) Figure 41. North America Animal Pharmaceutical Sales Share by Type (2021-2032) Figure 42. North America Animal Pharmaceutical Revenue Share by Application (2021-2032) Figure 43. North America Animal Pharmaceutical Sales Share by Application (2021-2032) Figure 44. North America Animal Pharmaceutical Revenue Share by Country (2021-2032) Figure 45. North America Animal Pharmaceutical Sales Share by Country (2021-2032) Figure 46. Europe Animal Pharmaceutical Revenue Share by Type (2021-2032) Figure 47. Europe Animal Pharmaceutical Sales Share by Type (2021-2032) Figure 48. Europe Animal Pharmaceutical Revenue Share by Application (2021-2032) Figure 49. Europe Animal Pharmaceutical Sales Share by Application (2021-2032) Figure 50. Europe Animal Pharmaceutical Revenue Share by Country (2021-2032) Figure 51. Europe Animal Pharmaceutical Sales Share by Country (2021-2032) Figure 52. China Animal Pharmaceutical Revenue Share by Type (2021-2032) Figure 53. China Animal Pharmaceutical Sales Share by Type (2021-2032) Figure 54. China Animal Pharmaceutical Revenue Share by Application (2021-2032) Figure 55. China Animal Pharmaceutical Sales Share by Application (2021-2032) Figure 56. Asia Animal Pharmaceutical Revenue Share by Type (2021-2032) Figure 57. Asia Animal Pharmaceutical Sales Share by Type (2021-2032) Figure 58. Asia Animal Pharmaceutical Revenue Share by Application (2021-2032) Figure 59. Asia Animal Pharmaceutical Sales Share by Application (2021-2032) Figure 60. Asia Animal Pharmaceutical Revenue Share by Country (2021-2032) Figure 61. Asia Animal Pharmaceutical Sales Share by Country (2021-2032) Figure 62. SAMEA Animal Pharmaceutical Revenue Share by Type (2021-2032) Figure 63. SAMEA Animal Pharmaceutical Sales Share by Type (2021-2032) Figure 64. SAMEA Animal Pharmaceutical Revenue Share by Application (2021-2032) Figure 65. SAMEA Animal Pharmaceutical Sales Share by Application (2021-2032) Figure 66. SAMEA Animal Pharmaceutical Revenue Share by Country (2021-2032) Figure 67. SAMEA Animal Pharmaceutical Sales Share by Country (2021-2032) Figure 68. Animal Pharmaceutical Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Animal Pharmaceutical Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Vaccine
  • Veterinary Drugs
  • Other
Applications
  • Companion Animal
  • Poultry
  • Other
Companies covered
  • Merck
  • Zoetis
  • Virbac
  • Vétoquinol
  • Ringpu Biology
  • PARNELL
  • MSD Animal Health Australia
  • Merial
  • Jurox
  • Elanco
  • Ceva Sante Animale
  • CAHIC
  • Boehringer Ingelheim Vetmedica
  • Bayer Animal Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Animal Pharmaceutical Market by Type
  3. 1.2.1 Global Animal Pharmaceutical Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Vaccine
  5. 1.2.3 Veterinary Drugs
  6. 1.2.4 Other
  7. 1.3 Animal Pharmaceutical Market by Application
  8. 1.3.1 Global Animal Pharmaceutical Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Companion Animal
  10. 1.3.3 Poultry
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Animal Pharmaceutical Market Dynamics
  1. 2.1 Animal Pharmaceutical Industry Trends
  2. 2.2 Animal Pharmaceutical Industry Drivers
  3. 2.3 Animal Pharmaceutical Industry Opportunities and Challenges
  4. 2.4 Animal Pharmaceutical Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Animal Pharmaceutical Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Animal Pharmaceutical Revenue by Region
  3. 3.2.1 Global Animal Pharmaceutical Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Animal Pharmaceutical Revenue by Region (2021-2026)
  5. 3.2.3 Global Animal Pharmaceutical Revenue by Region (2027-2032)
  6. 3.2.4 Global Animal Pharmaceutical Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Animal Pharmaceutical Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Animal Pharmaceutical Sales by Region
  9. 3.4.1 Global Animal Pharmaceutical Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Animal Pharmaceutical Sales by Region (2021-2026)
  11. 3.4.3 Global Animal Pharmaceutical Sales by Region (2027-2032)
  12. 3.4.4 Global Animal Pharmaceutical Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Animal Pharmaceutical Revenue by Manufacturers
  2. 4.1.1 Global Animal Pharmaceutical Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Animal Pharmaceutical Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Animal Pharmaceutical Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Animal Pharmaceutical Sales by Manufacturers
  6. 4.2.1 Global Animal Pharmaceutical Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Animal Pharmaceutical Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Animal Pharmaceutical Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Animal Pharmaceutical Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Animal Pharmaceutical Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Animal Pharmaceutical Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Animal Pharmaceutical Manufacturers, Product Type & Application
  13. 4.7 Global Animal Pharmaceutical Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Animal Pharmaceutical Market CR5 and HHI
  16. 4.8.2 2025 Animal Pharmaceutical Tier 1, Tier 2, and Tier 3
5 Animal Pharmaceutical Market by Type
  1. 5.1 Global Animal Pharmaceutical Revenue by Type
  2. 5.1.1 Global Animal Pharmaceutical Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Animal Pharmaceutical Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Animal Pharmaceutical Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Animal Pharmaceutical Sales by Type
  6. 5.2.1 Global Animal Pharmaceutical Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Animal Pharmaceutical Sales by Type (2021-2032) & (Tons)
  8. 5.2.3 Global Animal Pharmaceutical Sales Market Share by Type (2021-2032)
  9. 5.3 Global Animal Pharmaceutical Price by Type
6 Animal Pharmaceutical Market by Application
  1. 6.1 Global Animal Pharmaceutical Revenue by Application
  2. 6.1.1 Global Animal Pharmaceutical Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Animal Pharmaceutical Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Animal Pharmaceutical Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Animal Pharmaceutical Sales by Application
  6. 6.2.1 Global Animal Pharmaceutical Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Animal Pharmaceutical Sales by Application (2021-2032) & (Tons)
  8. 6.2.3 Global Animal Pharmaceutical Sales Market Share by Application (2021-2032)
  9. 6.3 Global Animal Pharmaceutical Price by Application
7 Company Profiles
  1. 7.1 Merck
  2. 7.1.1 Merck Company Information
  3. 7.1.2 Merck Business Overview
  4. 7.1.3 Merck Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Merck Animal Pharmaceutical Product Portfolio
  6. 7.1.5 Merck Recent Developments
  7. 7.2 Zoetis
  8. 7.2.1 Zoetis Company Information
  9. 7.2.2 Zoetis Business Overview
  10. 7.2.3 Zoetis Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Zoetis Animal Pharmaceutical Product Portfolio
  12. 7.2.5 Zoetis Recent Developments
  13. 7.3 Virbac
  14. 7.3.1 Virbac Company Information
  15. 7.3.2 Virbac Business Overview
  16. 7.3.3 Virbac Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Virbac Animal Pharmaceutical Product Portfolio
  18. 7.3.5 Virbac Recent Developments
  19. 7.4 Vétoquinol
  20. 7.4.1 Vétoquinol Company Information
  21. 7.4.2 Vétoquinol Business Overview
  22. 7.4.3 Vétoquinol Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Vétoquinol Animal Pharmaceutical Product Portfolio
  24. 7.4.5 Vétoquinol Recent Developments
  25. 7.5 Ringpu Biology
  26. 7.5.1 Ringpu Biology Company Information
  27. 7.5.2 Ringpu Biology Business Overview
  28. 7.5.3 Ringpu Biology Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Ringpu Biology Animal Pharmaceutical Product Portfolio
  30. 7.5.5 Ringpu Biology Recent Developments
  31. 7.6 PARNELL
  32. 7.6.1 PARNELL Company Information
  33. 7.6.2 PARNELL Business Overview
  34. 7.6.3 PARNELL Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 PARNELL Animal Pharmaceutical Product Portfolio
  36. 7.6.5 PARNELL Recent Developments
  37. 7.7 MSD Animal Health Australia
  38. 7.7.1 MSD Animal Health Australia Company Information
  39. 7.7.2 MSD Animal Health Australia Business Overview
  40. 7.7.3 MSD Animal Health Australia Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 MSD Animal Health Australia Animal Pharmaceutical Product Portfolio
  42. 7.7.5 MSD Animal Health Australia Recent Developments
  43. 7.8 Merial
  44. 7.8.1 Merial Company Information
  45. 7.8.2 Merial Business Overview
  46. 7.8.3 Merial Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Merial Animal Pharmaceutical Product Portfolio
  48. 7.8.5 Merial Recent Developments
  49. 7.9 Jurox
  50. 7.9.1 Jurox Company Information
  51. 7.9.2 Jurox Business Overview
  52. 7.9.3 Jurox Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Jurox Animal Pharmaceutical Product Portfolio
  54. 7.9.5 Jurox Recent Developments
  55. 7.10 Elanco
  56. 7.10.1 Elanco Company Information
  57. 7.10.2 Elanco Business Overview
  58. 7.10.3 Elanco Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Elanco Animal Pharmaceutical Product Portfolio
  60. 7.10.5 Elanco Recent Developments
  61. 7.11 Ceva Sante Animale
  62. 7.11.1 Ceva Sante Animale Company Information
  63. 7.11.2 Ceva Sante Animale Business Overview
  64. 7.11.3 Ceva Sante Animale Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Ceva Sante Animale Animal Pharmaceutical Product Portfolio
  66. 7.11.5 Ceva Sante Animale Recent Developments
  67. 7.12 CAHIC
  68. 7.12.1 CAHIC Company Information
  69. 7.12.2 CAHIC Business Overview
  70. 7.12.3 CAHIC Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 CAHIC Animal Pharmaceutical Product Portfolio
  72. 7.12.5 CAHIC Recent Developments
  73. 7.13 Boehringer Ingelheim Vetmedica
  74. 7.13.1 Boehringer Ingelheim Vetmedica Company Information
  75. 7.13.2 Boehringer Ingelheim Vetmedica Business Overview
  76. 7.13.3 Boehringer Ingelheim Vetmedica Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Boehringer Ingelheim Vetmedica Animal Pharmaceutical Product Portfolio
  78. 7.13.5 Boehringer Ingelheim Vetmedica Recent Developments
  79. 7.14 Bayer Animal Health
  80. 7.14.1 Bayer Animal Health Company Information
  81. 7.14.2 Bayer Animal Health Business Overview
  82. 7.14.3 Bayer Animal Health Animal Pharmaceutical Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Bayer Animal Health Animal Pharmaceutical Product Portfolio
  84. 7.14.5 Bayer Animal Health Recent Developments
8 North America
  1. 8.1 North America Animal Pharmaceutical Market Size by Type
  2. 8.1.1 North America Animal Pharmaceutical Revenue by Type (2021-2032)
  3. 8.1.2 North America Animal Pharmaceutical Sales by Type (2021-2032)
  4. 8.1.3 North America Animal Pharmaceutical Price by Type (2021-2032)
  5. 8.2 North America Animal Pharmaceutical Market Size by Application
  6. 8.2.1 North America Animal Pharmaceutical Revenue by Application (2021-2032)
  7. 8.2.2 North America Animal Pharmaceutical Sales by Application (2021-2032)
  8. 8.2.3 North America Animal Pharmaceutical Price by Application (2021-2032)
  9. 8.3 North America Animal Pharmaceutical Market Size by Country
  10. 8.3.1 North America Animal Pharmaceutical Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Animal Pharmaceutical Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Animal Pharmaceutical Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Animal Pharmaceutical Market Size by Type
  2. 9.1.1 Europe Animal Pharmaceutical Revenue by Type (2021-2032)
  3. 9.1.2 Europe Animal Pharmaceutical Sales by Type (2021-2032)
  4. 9.1.3 Europe Animal Pharmaceutical Price by Type (2021-2032)
  5. 9.2 Europe Animal Pharmaceutical Market Size by Application
  6. 9.2.1 Europe Animal Pharmaceutical Revenue by Application (2021-2032)
  7. 9.2.2 Europe Animal Pharmaceutical Sales by Application (2021-2032)
  8. 9.2.3 Europe Animal Pharmaceutical Price by Application (2021-2032)
  9. 9.3 Europe Animal Pharmaceutical Market Size by Country
  10. 9.3.1 Europe Animal Pharmaceutical Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Animal Pharmaceutical Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Animal Pharmaceutical Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Animal Pharmaceutical Market Size by Type
  2. 10.1.1 China Animal Pharmaceutical Revenue by Type (2021-2032)
  3. 10.1.2 China Animal Pharmaceutical Sales by Type (2021-2032)
  4. 10.1.3 China Animal Pharmaceutical Price by Type (2021-2032)
  5. 10.2 China Animal Pharmaceutical Market Size by Application
  6. 10.2.1 China Animal Pharmaceutical Revenue by Application (2021-2032)
  7. 10.2.2 China Animal Pharmaceutical Sales by Application (2021-2032)
  8. 10.2.3 China Animal Pharmaceutical Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Animal Pharmaceutical Market Size by Type
  2. 11.1.1 Asia Animal Pharmaceutical Revenue by Type (2021-2032)
  3. 11.1.2 Asia Animal Pharmaceutical Sales by Type (2021-2032)
  4. 11.1.3 Asia Animal Pharmaceutical Price by Type (2021-2032)
  5. 11.2 Asia Animal Pharmaceutical Market Size by Application
  6. 11.2.1 Asia Animal Pharmaceutical Revenue by Application (2021-2032)
  7. 11.2.2 Asia Animal Pharmaceutical Sales by Application (2021-2032)
  8. 11.2.3 Asia Animal Pharmaceutical Price by Application (2021-2032)
  9. 11.3 Asia Animal Pharmaceutical Market Size by Country
  10. 11.3.1 Asia Animal Pharmaceutical Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Animal Pharmaceutical Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Animal Pharmaceutical Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Animal Pharmaceutical Market Size by Type
  2. 12.1.1 SAMEA Animal Pharmaceutical Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Animal Pharmaceutical Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Animal Pharmaceutical Price by Type (2021-2032)
  5. 12.2 SAMEA Animal Pharmaceutical Market Size by Application
  6. 12.2.1 SAMEA Animal Pharmaceutical Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Animal Pharmaceutical Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Animal Pharmaceutical Price by Application (2021-2032)
  9. 12.3 SAMEA Animal Pharmaceutical Market Size by Country
  10. 12.3.1 SAMEA Animal Pharmaceutical Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Animal Pharmaceutical Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Animal Pharmaceutical Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Animal Pharmaceutical Value Chain Analysis
  2. 13.1.1 Animal Pharmaceutical Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Animal Pharmaceutical Production Mode & Process
  6. 13.2 Animal Pharmaceutical Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Animal Pharmaceutical Distributors
  9. 13.2.3 Animal Pharmaceutical Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research